: iStockAnalyst.com Symbols Feed

The Easiest Strategy To Double Your Money In Two Months - CLRSO, PDLI

Fri, 11 Sep 2009 19:26:08 GMT

PDL Biopharma squandered its fortune. PDL was one of biotech's earliest success stories... Its scientists developed techniques that made possible some of the most successful biotech drugs to date. Today, the company still fetches more than $300 million per year in royalties from top-selling cancer drugs like Genentech's Avastin and Herceptin.[More...]

Spectrum Pharma (NASDAQ:SPPI): Undervalued Based On Late-Stage Pipeline

Fri, 19 Jun 2009 16:45:08 GMT

With two potential approvals coming up in the next 120 days, Spectrum Pharmaceuticals (Nasdaq: SPPI) still remains a hidden gem. Investor's Business Daily bases its rankings on the relationship that one company has with other companies within the same industry. In my June 12 article, I indicated the company could likely generate $280 million in annual revenue within the next 12-18 months upon approval of both the company's cancer drugs Zevalin and Fusilev. The table below is a lis (...)[More...]

Hedge Fund Best Ideas and Consensus Follow-Up

Thu, 15 Jan 2009 21:00:00 GMT

In late 2006 I proposed tracking a portfolio of 10 hedge fund managers I considered to be great stockpickers. In sounded good to me in theory, but I always like to let the data speak for itself so I then went and backtested two strategies based on their 13F filings. Top Holdings - This selected the top 2 holdings from each manager to form a portfolio of 20 holdings. Consensus - This selected the most popular ten holdings among the managers. The ten managers were: Baupost Group Blue Ridge Capital Warren Buffett Eminence Capital Greenlight Capital Lone Pine Capital Maverick Capital Okumus Capital Private Capital Tiger Global This process literally took me and a co-worker a month to complete by hand. I found that these two naive strategies of[More...]

Earnings Preview For Nov 3 - 7 - Earnings Preview

Sat, 01 Nov 2008 01:58:00 GMT

Companies that could issue positive surprises include Becton, Dickinson and Company (BDX), SucessFactors (SFSF) and Sunoco (SUN). Penn Virginia Corporation (PVA) could potentially disappoint investors. The Week's Events November has historically been one of the best months for the major markets, according to the[More...]

Institutional Money Flocking in Biotech

Fri, 15 Aug 2008 17:18:00 GMT

One area you can see I've been transitioning into is healthcare. I still don't buy the "technology is a safe haven" thesis but I have to respect that's where money flow is going. Healthcare I can feel a bit more comfortable with because it's a traditional[More...]

Few Thoughts and a Look at the Earnings in the Coming Week

Mon, 28 Jul 2008 05:15:00 GMT

WITH RESPECT TO THE US’ GDP GROWTH, THE NATIONAL BUREAU OF ECONOMIC RESEARCH SEES A SIGNIFICANT DECLINE IN ECONOMIC ACTITIVY SPREAD ACROSS THE ECONOMY, WHICH WILL LAST MORE THAN A FEW MONTHS - WSJ - According to Robert Hall, economist at Stanford University, US economic data that has been reported provide (...)[More...]

More Bad News From Financials

Fri, 09 May 2008 13:59:49 GMT

Good morning. As oil prices hit fresh new highs, more bad news from the financials are bringing out the sellers this morning.[More...]

Biotechs Coming Alive:

Tue, 15 Apr 2008 06:11:24 GMT

The market was stronger today, boosted by a rally in the biotech sector. The agricultural stocks also continued to show strength. In addition, steel stocks displayed solid performances. The Dow was up +54.72 points; SPX added +6.06 points; and Nasdaq gained +29.58 points. Here’s how the market looked at the close:BTK (biotech) jumped +4.81%, while INX2 (internet) and SOX (semiconductors) made modest gains. HGX (housing) added +1.14%, but XLF (finan[More...]

Media Digest for 4/14

Mon, 14 Apr 2008 14:28:36 GMT

Submitted by Optiondragon[More...]

Is Bad News Already Priced In?

Fri, 11 Apr 2008 14:11:43 GMT

Good morning. Premarket futures are pointing to a rough day after General Electric (GE) surprised Wall Street by reporting lower than expected earnings. This news will help test the market's hope that bad earnings news today and later this month is alread[More...]

Google, Amgen, Tyson Foods are big movers - Mar 27 2009 10:12PM

Sat, 28 Mar 2009 02:07:00 GMT

NEW YORK - Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and Nasdaq Stock Market:
The world's largest meat producer will close a meat processing plant in Ponca City, Okla., which means it may cut 580 jobs.
Johnson Controls Inc., down 36 cents at $12.54

[More...]

Google, Amgen, Tyson Foods are big movers - Mar 27 2009 2:05PM

Fri, 27 Mar 2009 18:00:00 GMT

NEW YORK - Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and Nasdaq Stock Market:
Tyson Foods Inc., down 10 cents at $9.83
Johnson Controls Inc., down 35 cents at $12.55

[More...]

PDL BioPharma Elects Barry Selick to Its Board of Directors

Mon, 03 Aug 2009 12:27:00 GMT

PDL BioPharma, Inc. today announced the appointment of Harold E. Selick, Ph.D., to the Company's Board of Directors.[More...]

PDL BioPharma Announces Second Quarter 2009 Financial Results

Thu, 30 Jul 2009 19:57:00 GMT

PDL BioPharma, Inc. today reported financial results for the second quarter ended June 30, 2009.[More...]

PDL BioPharma to Present at BMO Capital Markets Healthcare Conference on August 5, 2009

Wed, 29 Jul 2009 20:11:00 GMT

PDL BioPharma, Inc. today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the BMO Capital Markets Healthcare Conference in New York City on Wednesday, August 5, 2009 at 3:30 p.m. Eastern Time.[More...]

PDL BioPharma to Announce Second Quarter 2009 Financial Results and Hold Conference Call July 30, 2009

Wed, 22 Jul 2009 23:36:00 GMT

PDL BioPharma, Inc. today announced that the company will hold a conference call and webcast on Thursday, July 30 at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter of 2009 and provide a business update. The call and webcast will follow the release of the second quarter ended June 30, 2009 financial results after market close.Conference Call DetailsTo access the live conference call via phone, please dial 510-0707 from the United States and Canada or 597-5376 internationally. The conference ID is 27369299. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through August 6, and may be accessed by dialing 286-8010 from the United States and Canada or 801-6888 internationally. The replay passcode is 58547023.To access the live and subsequently archived webcast of the conference call, go to the company's Web site at http://www.pdl.com and click "Investors." Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary.About PDL BioPharma, Inc. PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in late 2014. For more information, please visit www.pdl.com. NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.[More...]

PDL BioPharma Announces Record Date for October 1 Dividend Payment

Wed, 10 Jun 2009 12:26:00 GMT

PDL BioPharma, Inc. today announced that all shareholders owning shares of PDL on September 17, 2009, will be paid a dividend of $0.50 per share on October 1, 2009. The Company previously announced that it would pay two dividends, each in the amount of $0.50 per share, to its stockholders in 2009. The first dividend was paid on April 1, 2009 to all stockholders who owned shares of PDL on March 16, 2009.[More...]

PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million

Mon, 08 Jun 2009 13:49:00 GMT

INCLINE VILLAGE, Nev., June 8 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the second quarter ended June 30, 2009 of approximately $125 million, as compared with $106 million for the second quarter of 2008.
When compared with 2008, royalty revenue for foreign sourced sales was negatively impacted by changes in foreign exchange rates; approximately 50 percent of underlying product sales is in currencies other than U.S. dollars.
PDL plans to release its financial results for the second quarter 2009 on August 6, and will hold a conference call to discuss financial results and provide an update on company activities.

[More...]

PDL BioPharma to Present at the 8th Annual JMP Securities Research Conference on May 18, 2009

Tue, 12 May 2009 11:57:00 GMT

PDL BioPharma, Inc. today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the 8th Annual JMP Securities Research Conference in San Francisco, Calif., on May 18, 2009 at 2:30 p.m. Pacific Time.[More...]

PDL BioPharma Announces First Quarter 2009 Financial Results

Thu, 07 May 2009 19:57:00 GMT

- Revenues From Continuing Operations Increase 25 Percent to $62.6 Million -[More...]

Facet Biotech Reports First Quarter 2009 Financial Results

Tue, 05 May 2009 20:57:00 GMT

Summary of Financial Results
The financial results for the quarter ended March 31, 2009 represent the first full quarter of operations for Facet as an independent company since its spin-off from PDL BioPharma, Inc. (PDL) on December 18, 2008.
The results for the quarter ended March 31, 2008 are comprised of the results of PDL's former biotechnology operations, which were derived from PDL's historical consolidated financial statements, prior to the spin-off.

[More...]

PDL BioPharma To Announce First Quarter 2009 Financial Results and Hold Conference Call May 7, 2009

Thu, 30 Apr 2009 11:57:00 GMT

PDL BioPharma, Inc. today announced that the company will hold a conference call and webcast on Thursday, May 7 at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter of 2009 and provide a business update. The call and webcast will follow the release of the first quarter ended March 31, 2009 financial results after market close.[More...]